Latest AbbVie Inc. Stories

- Reports First-Quarter Adjusted EPS of $0.68, GAAP EPS of $0.60 NORTH CHICAGO, Ill., April 26, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced financial results for the first quarter ended March 31, 2013. "In our first quarter as an independent company, AbbVie delivered earnings per share above our original guidance," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "The business generated strong sales growth despite loss of exclusivity in...

LONDON, April 10, 2013 /PRNewswire/ -- The Dow Jones Index closed at an all time high at 14,673.46, up 0.41 percent while NASDAQ was up 0.48 percent to end yesterday's session at 3,237.86. Similarly, S&P also finished Tuesday's trading session on a positive note at 1,568.61, up 0.35 percent. The markets showed across the board improvement and a bullish trend. Our research team took a look at the Healthcare sector, focusing on the major drug makers industry which include...

NEW YORK, March 7, 2013 /PRNewswire/ -- Today, Investors Alliance announced new research reports highlighting Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK), AbbVie Inc. (NYSE: ABBV), Novartis AG (NYSE: NVS), and GlaxoSmithKline Plc (NYSE: GSK). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Johnson & Johnson Research Report Since the...

NORTH CHICAGO, Ill., Feb. 15, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend and also authorized a share repurchase program of up to $1.5 billion of the Company's outstanding common stock. The cash dividend of $0.40 per share is payable May 15, 2013 to stockholders of record at the close of business on April 15, 2013. AbbVie was named to the S&P 500 Dividend Aristocrats Index, which tracks companies that have...

LONDON, January 28, 2013 /PRNewswire/ -- Last year, the U.S. Supreme Court upheld President Obama's Affordable Care Act, which is expected to have a significant impact on major drug manufacturers. In order to minimize the impact of Affordable Care Act, drug manufacturers have implemented new strategies. One such company is Abbott Laboratories (NYSE: ABT), which recently spun off its proprietary drug business into AbbVie (NYSE: ABBV). StockCall has compiled comprehensive...

HONG KONG, Jan. 17, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and equity research for the following companies: Citigroup (NYSE:C), EMC (NYSE:EMC), AbbVie (NYSE:ABBV), Mondelez International (NASDAQ:MDLZ), U.S. Bancorp (NYSE:USB), and KeyCorp (NYSE:KEY). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights:...

HONG KONG, Jan. 9, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and equity researchfor the following companies: Verizon (NYSE:VZ), Goldcorp (NYSE:GG), Celgene (NASDAQ:CELG), Alpha Natural Resources (NYSE:ANR), American International Group (NYSE:AIG), and AbbVie (NYSE:ABBV). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

NORTH CHICAGO, Ill., Jan. 4, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, today declared the Company's first quarterly cash dividend of $0.40 per share. The cash dividend is payable Feb. 15, 2013 to stockholders of record at the close of business on Jan. 15, 2013. AbbVie began trading on the New York Stock Exchange (NYSE) on Jan. 2, 2013 under the symbol "ABBV" and was also added to the S&P 500 Index. About...

ABBOTT PARK, Ill., Dec. 7, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the Securities and Exchange Commission (SEC) has declared effective the Form 10 Registration Statement filed by AbbVie Inc., its research-based pharmaceuticals business. Abbott expects to complete the separation of AbbVie on Jan. 1, 2013. On Nov. 28, 2012, Abbott's board of directors approved the separation of AbbVie, and declared a special dividend distribution of one share of AbbVie common...

ABBOTT PARK, Ill., Nov. 28, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that its board of directors has approved the separation of its research-based pharmaceuticals business, which will be known as AbbVie Inc., and declared a special dividend distribution of all of the outstanding shares of AbbVie common stock. For every 1 share of Abbott common shares held, Abbott shareholders will receive 1 share of AbbVie common stock. No fractional shares of AbbVie will be...